{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Omicron XBB.1.16",
      "SARS-CoV-2",
      "cross-protection",
      "homodimer",
      "receptor-binding domain"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "37843372",
  "DateCompleted": {
    "Year": "2023",
    "Month": "12",
    "Day": "06"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "12",
    "Day": "06"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "10",
        "Day": "16"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e01279-23",
      "10.1128/jvi.01279-23"
    ],
    "Journal": {
      "ISSN": "1098-5514",
      "JournalIssue": {
        "Volume": "97",
        "Issue": "11",
        "PubDate": {
          "Year": "2023",
          "Month": "Nov",
          "Day": "30"
        }
      },
      "Title": "Journal of virology",
      "ISOAbbreviation": "J Virol"
    },
    "ArticleTitle": "Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants.",
    "Pagination": {
      "StartPage": "e0127923",
      "MedlinePgn": "e0127923"
    },
    "Abstract": {
      "AbstractText": [
        "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants achieved immune escape and became less virulent and easily transmissible through rapid mutation in the spike protein, thus the efficacy of vaccines on the market or in development continues to be challenged. Updating the vaccine, exploring compromise vaccination strategies, and evaluating the efficacy of candidate vaccines for the emerging variants in a timely manner are important to combat complex and volatile SARS-CoV-2. This study reports that vaccines prepared from the dimeric receptor-binding domain (RBD) recombinant protein, which can be quickly produced using a mature and stable process platform, had both good immunogenicity and protection <i>in vivo</i> and could completely protect rodents from lethal challenge by SARS-CoV-2 and its variants, including the emerging Omicron XBB.1.16, highlighting the value of dimeric recombinant vaccines in the post-COVID-19 era."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-0928-6127"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences , Wuhan, China."
          }
        ],
        "LastName": "Wu",
        "ForeName": "Yan",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Wuhan YZY Biopharma Co., Ltd. , Wuhan, China."
          }
        ],
        "LastName": "Shi",
        "ForeName": "Jian",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences , Wuhan, China."
          }
        ],
        "LastName": "He",
        "ForeName": "Xiaoxue",
        "Initials": "X"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences , Wuhan, China."
          },
          {
            "Identifier": [],
            "Affiliation": "University of the Chinese Academy of Sciences , Beijing, China."
          }
        ],
        "LastName": "Lu",
        "ForeName": "Jia",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences , Wuhan, China."
          },
          {
            "Identifier": [],
            "Affiliation": "University of the Chinese Academy of Sciences , Beijing, China."
          }
        ],
        "LastName": "Gao",
        "ForeName": "Xiao",
        "Initials": "X"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences , Wuhan, China."
          }
        ],
        "LastName": "Zhu",
        "ForeName": "Xuerui",
        "Initials": "X"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences , Wuhan, China."
          },
          {
            "Identifier": [],
            "Affiliation": "University of the Chinese Academy of Sciences , Beijing, China."
          }
        ],
        "LastName": "Chen",
        "ForeName": "Xinlan",
        "Initials": "X"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Wuhan YZY Biopharma Co., Ltd. , Wuhan, China."
          }
        ],
        "LastName": "Zhang",
        "ForeName": "Man",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Wuhan YZY Biopharma Co., Ltd. , Wuhan, China."
          }
        ],
        "LastName": "Fang",
        "ForeName": "Lijuan",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Wuhan YZY Biopharma Co., Ltd. , Wuhan, China."
          }
        ],
        "LastName": "Zhang",
        "ForeName": "Jing",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences , Wuhan, China."
          },
          {
            "Identifier": [],
            "Affiliation": "University of the Chinese Academy of Sciences , Beijing, China."
          },
          {
            "Identifier": [],
            "Affiliation": "Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences , Wuhan, China."
          }
        ],
        "LastName": "Yuan",
        "ForeName": "Zhiming",
        "Initials": "Z"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences , Wuhan, China."
          },
          {
            "Identifier": [],
            "Affiliation": "University of the Chinese Academy of Sciences , Beijing, China."
          },
          {
            "Identifier": [],
            "Affiliation": "Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences , Wuhan, China."
          }
        ],
        "LastName": "Xiao",
        "ForeName": "Gengfu",
        "Initials": "G"
      },
      {
        "Identifier": [
          "0000-0001-6335-7769"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Wuhan YZY Biopharma Co., Ltd. , Wuhan, China."
          }
        ],
        "LastName": "Zhou",
        "ForeName": "Pengfei",
        "Initials": "P"
      },
      {
        "Identifier": [
          "0000-0003-0553-5138"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences , Wuhan, China."
          },
          {
            "Identifier": [],
            "Affiliation": "University of the Chinese Academy of Sciences , Beijing, China."
          },
          {
            "Identifier": [],
            "Affiliation": "Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences , Wuhan, China."
          }
        ],
        "LastName": "Pan",
        "ForeName": "Xiaoyan",
        "Initials": "X"
      }
    ],
    "GrantList": [
      {
        "GrantID": "2021333",
        "Agency": "The youth innovation promotion association of CAS",
        "Country": ""
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Virol",
    "NlmUniqueID": "0113724",
    "ISSNLinking": "0022-538X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Neutralizing"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Viral"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Polymers"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Spike Glycoprotein, Coronavirus"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "spike protein, SARS-CoV-2"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Antibodies, Neutralizing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Antibodies, Viral"
    },
    {
      "QualifierName": [
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mutation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Polymers"
    },
    {
      "QualifierName": [
        "classification",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "chemistry"
      ],
      "DescriptorName": "Spike Glycoprotein, Coronavirus"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    }
  ],
  "CoiStatement": "Authors J.S., M.Z., L.F., J.Z., and P.Z. are employees of Wuhan YZY Biopharma Co., Ltd., a for-profit organization, and these authors own stock or hold stock options. J.S., L.F., J.Z., P.Z., X.P., and G.X. are listed as coinventors in one patent. These interests do not alter the authors' adherence to policies on sharing data and materials. The other authors declare no competing financial interests."
}